<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-020</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8170</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>РЕПРОДУКТИВНОЕ ЗДОРОВЬЕ И ВРТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REPRODUCTIVE HEALTH AND ART</subject></subj-group></article-categories><title-group><article-title>Полиморфизм rs117585797 гена ANO2 как генетический маркер высокого риска развития сочетанных пролиферативных заболеваний матки у женщин с эндометриозом</article-title><trans-title-group xml:lang="en"><trans-title>Polymorphism rs117585797 of the ANO2 gene as a genetic marker of a high risk of developing combined proliferative diseases of the uterus in women with endometriosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7155-6255</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Головченко</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Golovchenko</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Головченко Илья Олегович, аспирант кафедры медико-биологических дисциплин Медицинского института</p><p>308015, Белгород, ул. Победы, д. 85</p></bio><bio xml:lang="en"><p>Ilya O. Golovchenko, Postgraduate Student, Department of Biomedical Disciplines of the Medical Institut</p><p>85, Pobedy St., Belgorod, 308015</p></bio><email xlink:type="simple">ilyagolovchenko1@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5652-0166</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономаренко</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пономаренко Ирина Васильевна, д.м.н., доцент, профессор кафедры медико-биологических дисциплин Медицинского института</p><p>308015, Белгород, ул. Победы, д. 85</p></bio><bio xml:lang="en"><p>Irina V. Ponomarenko, Dr. Sci. (Med.), Associate Professor, Professor of the Department of Biomedical Disciplines of the Medical Institute</p><p>85, Pobedy St., Belgorod, 308015</p></bio><email xlink:type="simple">ponomarenko_i@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1254-6134</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чурносов</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Churnosov</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чурносов Михаил Иванович, д.м.н., профессор, заведующий кафедрой медико-биологических дисциплин Медицинского института</p><p>308015, Белгород, ул. Победы, д. 85</p></bio><bio xml:lang="en"><p>Mikhail I. Churnosov, Dr. Sci. (Med.), Professor, Head of the Department of Biomedical Disciplines of the Medical Institute</p><p>85, Pobedy St., Belgorod, 308015</p></bio><email xlink:type="simple">churnosov@bsu.edu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Белгородский государственный национальный исследовательский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Belgorod State National Research University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>05</month><year>2024</year></pub-date><volume>0</volume><issue>4</issue><fpage>12</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Головченко И.О., Пономаренко И.В., Чурносов М.И., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Головченко И.О., Пономаренко И.В., Чурносов М.И.</copyright-holder><copyright-holder xml:lang="en">Golovchenko I.O., Ponomarenko I.V., Churnosov M.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8170">https://www.med-sovet.pro/jour/article/view/8170</self-uri><abstract><sec><title>Введение</title><p>Введение. Эндометриоз представляет собой распространенное гинекологическое заболевание, которое имеет важное социально-экономическое значение как для больных женщин, их семей, так и общества в целом. Нередко он сочетается с другими гиперпластическими заболеваниями матки.</p></sec><sec><title>Цель</title><p>Цель. Провести анализ вовлеченности GWAS-значимых полиморфных локусов генов половых гормонов в развитие сочетанных пролиферативных заболеваний матки у женщин с эндометриозом.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Выборка для исследования включала 395 женщин, среди которых 103 пациентки с изолированным эндометриозом и 292 пациентки с эндометриозом в сочетании с миомой матки и/или гиперплазией эндометрия. Всем женщинам выполнено молекулярно-генетическое тестирование семи GWAS-значимых однонуклеотидных полиморфных вариантов генов половых гормонов (rs34670419, rs11031005, rs11031002, rs148982377, rs112295236, rs1641549, rs117585797). Проведен анализ ассоциаций полиморфных вариантов с риском развития сочетанных пролиферативных заболеваний матки у пациенток с эндометриозом. Для оценки функциональных эффектов SNP, связанного с формированием сочетанных пролиферативных заболеваний матки у женщин с эндометриозом, применялись онлайн-программы HaploReg и Gtex Portal.</p></sec><sec><title>Результаты и обсуждение</title><p>Результаты и обсуждение. Генетический вариант А rs117585797 гена ANO2 является рисковым фактором развития сочетанных пролиферативных заболеваний матки у женщин с эндометриозом (р = 0,05, рperm = 0,05, OR = 4,29). Согласно полученным in silico данным, локус rs117585797, локализованный в интроне гена ANO2, влияет на сродство регуляторного мотива ДНК к факторам транскрипции Crx и Gsc.</p></sec><sec><title>Выводы</title><p>Выводы. Полиморфный локус rs117585797 гена ANO2 связан с высоким риском формирования сочетанных пролиферативных заболеваний матки у пациенток с эндометриозом.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Endometriosis is a common gynecological disease that has important socio-economic significance for both sick women, their families, and society as a whole. It is often combined with other hyperplastic diseases of the uterus.</p></sec><sec><title>Aim</title><p>Aim. To analyze the involvement of GWAS-significant polymorphic loci of sex hormone genes in the development of combined proliferative diseases of the uterus in women with endometriosis. </p></sec><sec><title>Materials and methods</title><p>Materials and methods. The sample for the study included 395 women, including 103 patients with isolated endometriosis and 292 patients with endometriosis in combination with uterine fibroids and/or endometrial hyperplasia. All women underwent molecular genetic testing of seven GWAS-significant single-nucleotide polymorphic variants of sex hormone genes (rs34670419, rs11031005, rs11031002, rs148982377, rs112295236, rs1641549, rs117585797). The analysis of associations of polymorphic variants with the risk of developing combined proliferative diseases of the uterus in patients with endometriosis was carried out. To assess the functional effects of SNP associated with the formation of combined proliferative diseases of the uterus in women with endometriosis, the online programs HaploReg and Gtex Portal were used.</p></sec><sec><title>Results and discussion</title><p>Results and discussion. Genetic variant A rs117585797 of the ANO2 gene is a risk factor for the development of combined proliferative diseases of the uterus in women with endometriosis (p = 0.05, рperm = 0.05, OR = 4.29). According to the data obtained in silico, the rs117585797 locus localized in the intron of the ANO2 gene affects the affinity of the regulatory DNA motif to the transcription factors Crx and Gsc.</p></sec><sec><title>Conclusions</title><p>Conclusions. Polymorphic locus rs117585797 of the ANO2 gene is associated with a high risk of the formation of combined proliferative diseases of the uterus in patients with endometriosis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>эндометриоз</kwd><kwd>сочетанные пролиферативные заболевания матки</kwd><kwd>ассоциации</kwd><kwd>полиморфизм</kwd><kwd>ANO2</kwd><kwd>rs117585797</kwd></kwd-group><kwd-group xml:lang="en"><kwd>endometriosis</kwd><kwd>combined proliferative diseases of the uterus</kwd><kwd>associations</kwd><kwd>polymorphism</kwd><kwd>ANO2</kwd><kwd>rs117585797</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при финансовой поддержке гранта Президента РФ «Изучение генетических факторов репродуктивного здоровья женщин» (МД3284.2022.1.4)</funding-statement><funding-statement xml:lang="en">The work was conducted with financial support from the Russian Federation President Grant – Studying Genetic Factors Contributing to Women’s Reproductive Health (MD3284.2022.1.4)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Адамян ЛВ, Андреева ЕН. Эндометриоз и его глобальное влияние на организм женщины. Проблемы репродукции. 2022;28(1):54–64. https://doi.org/10.17116/repro20222801154.</mixed-citation><mixed-citation xml:lang="en">Adamyan LV, Andreeva EN. Endometriosis and its global impact on a woman’s body. Russian Journal of Human Reproduction. 2022;28(1):54–64. (In Russ.) https://doi.org/10.17116/repro20222801154.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Smolarz B, Szyłło K, Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). Int J Mol Sci. 2021;22(19):10554. https://doi.org/10.3390/ijms221910554.</mixed-citation><mixed-citation xml:lang="en">Smolarz B, Szyłło K, Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). Int J Mol Sci. 2021;22(19):10554. https://doi.org/10.3390/ijms221910554.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Coccia ME, Nardone L, Rizzello F. Endometriosis and Infertility: A Long-Life Approach to Preserve Reproductive Integrity. Int J Environ Res Public Health. 2022;19(10):6162. http://doi.org/10.3390/ijerph19106162.</mixed-citation><mixed-citation xml:lang="en">Coccia ME, Nardone L, Rizzello F. Endometriosis and Infertility: A Long-Life Approach to Preserve Reproductive Integrity. Int J Environ Res Public Health. 2022;19(10):6162. http://doi.org/10.3390/ijerph19106162.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. http://doi.org/10.1056/NEJMra1810764.</mixed-citation><mixed-citation xml:lang="en">Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244–1256. http://doi.org/10.1056/NEJMra1810764.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bonavina G, Taylor HS. Endometriosis-associated infertility: From pathophysiology to tailored treatment. Front Endocrinol (Lausanne). 2022;13:1020827. http://doi.org/10.3389/fendo.2022.1020827.</mixed-citation><mixed-citation xml:lang="en">Bonavina G, Taylor HS. Endometriosis-associated infertility: From pathophysiology to tailored treatment. Front Endocrinol (Lausanne). 2022;13:1020827. http://doi.org/10.3389/fendo.2022.1020827.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Радзинский ВЕ, Алтухова ОБ. Молекулярно-генетические детерминанты бесплодия при генитальном эндометриозе. Научные результаты биомедицинских исследований. 2018;4(3):28–37. http://doi.org/10.18413/2313-8955-2018-4-3-0-3.</mixed-citation><mixed-citation xml:lang="en">Radzinsky VE, Altuchova OB. Molecular-genetic determinants of infertility in genital endometryosis. Research Results in Biomedicine. 2018;4(3):28–37. (In Russ.) http://doi.org/10.18413/2313-8955-2018-4-3-0-3.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Головченко ИО, Пономаренко ИВ, Чурносов МИ. Современные данные об этиопатогенезе и факторах риска развития эндометриоза. Российский вестник акушера-гинеколога. 2021;21(5):41–48. https://doi.org/10.17116/rosakush20212105141.</mixed-citation><mixed-citation xml:lang="en">Golovchenko IO, Ponomarenko IV, Churnosov MI. Modern view on the etiology-pathogenesis and risk factors of endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2021;21(5):41–48. (In Russ.) https://doi.org/10.17116/rosakush20212105141.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S et al. Impact of Endometriosis on Life-Course Potential: A Narrative Review. Int J Gen Med. 2021;14:9–25. http://doi.org/10.2147/IJGM.S261139.</mixed-citation><mixed-citation xml:lang="en">Missmer SA, Tu FF, Agarwal SK, Chapron C, Soliman AM, Chiuve S et al. Impact of Endometriosis on Life-Course Potential: A Narrative Review. Int J Gen Med. 2021;14:9–25. http://doi.org/10.2147/IJGM.S261139.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Troìa L, Luisi S. Sexual function and quality of life in women with endometriosis. Minerva Obstet Gynecol. 2022;74(3):203–221. http://doi.org/10.23736/S2724-606X.22.05033-3.</mixed-citation><mixed-citation xml:lang="en">Troìa L, Luisi S. Sexual function and quality of life in women with endometriosis. Minerva Obstet Gynecol. 2022;74(3):203–221. http://doi.org/10.23736/S2724-606X.22.05033-3.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Darbà J, Marsà A. Economic Implications of Endometriosis: A Review. Pharmacoeconomics. 2022;40(12):1143–1158. http://doi.org/10.1007/s40273-022-01211-0.</mixed-citation><mixed-citation xml:lang="en">Darbà J, Marsà A. Economic Implications of Endometriosis: A Review. Pharmacoeconomics. 2022;40(12):1143–1158. http://doi.org/10.1007/s40273-022-01211-0.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Staal AH, van der Zanden M, Nap AW. Diagnostic Delay of Endometriosis in the Netherlands. Gynecol Obstet Invest. 2016;81(4):321–324. http://doi.org/10.1159/000441911.</mixed-citation><mixed-citation xml:lang="en">Staal AH, van der Zanden M, Nap AW. Diagnostic Delay of Endometriosis in the Netherlands. Gynecol Obstet Invest. 2016;81(4):321–324. http://doi.org/10.1159/000441911.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis Diagnosis in the United States. J Womens Health (Larchmt). 2017;26(7):788–797. http://doi.org/10.1089/jwh.2016.6003.</mixed-citation><mixed-citation xml:lang="en">Soliman AM, Fuldeore M, Snabes MC. Factors Associated with Time to Endometriosis Diagnosis in the United States. J Womens Health (Larchmt). 2017;26(7):788–797. http://doi.org/10.1089/jwh.2016.6003.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1-354.e12. http://doi.org/10.1016/j.ajog.2018.12.039.</mixed-citation><mixed-citation xml:lang="en">Agarwal SK, Chapron C, Giudice LC, Laufer MR, Leyland N, Missmer SA et al. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019;220(4):354.e1-354.e12. http://doi.org/10.1016/j.ajog.2018.12.039.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Surrey ES, Soliman AM, Johnson SJ, Davis M, Castelli-Haley J, Snabes MC. Risk of Developing Comorbidities Among Women with Endometriosis: A Retrospective Matched Cohort Study. J Womens Health (Larchmt). 2018;27(9):1114–1123. http://doi.org/10.1089/jwh.2017.6432.</mixed-citation><mixed-citation xml:lang="en">Surrey ES, Soliman AM, Johnson SJ, Davis M, Castelli-Haley J, Snabes MC. Risk of Developing Comorbidities Among Women with Endometriosis: A Retrospective Matched Cohort Study. J Womens Health (Larchmt). 2018;27(9):1114–1123. http://doi.org/10.1089/jwh.2017.6432.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Адамян ЛВ (ред.). Cочетанные доброкачественные опухоли и гиперпластические процессы матки (миома, аденомиоз, гиперплазия эндометрия). Проект клинических рекомендаций по ведению больных. М.: Изд-во Научного центра акушерства, гинекологии и перинатологии им. В.И. Кулакова; 2015. 92 с.</mixed-citation><mixed-citation xml:lang="en">Адамян ЛВ (ред.). Cочетанные доброкачественные опухоли и гиперпластические процессы матки (миома, аденомиоз, гиперплазия эндометрия). Проект клинических рекомендаций по ведению больных. М.: Изд-во Научного центра акушерства, гинекологии и перинатологии им. В.И. Кулакова; 2015. 92 с.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Щукина НА, Буянова СН, Бабунашвили ЕЛ, Тихомирова ЕВ, Земскова НЮ, Глебов ТА. Современные подходы к медикаментозному лечению пациенток с сочетанными пролиферативными заболеваниями матки. Российский вестник акушера-гинеколога. 2022;22(6):102–108. https://doi.org/10.17116/rosakush202222061102.</mixed-citation><mixed-citation xml:lang="en">Schukina NA, Buyanova SN, Babunashvili EL, Tikhomirova EV, Zemskova NYu, Glebov TA. Current approaches to drug therapy in patients with concomitant proliferative uterine diseases. Russian Bulletin of ObstetricianGynecologist. 2022;22(6):102–108. (In Russ.) https://doi.org/10.17116/rosakush202222061102.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Uimari O, Nazri H, Tapmeier T. Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications. Front Reprod Health. 2021;3:750018. http://doi.org/10.3389/frph.2021.750018.</mixed-citation><mixed-citation xml:lang="en">Uimari O, Nazri H, Tapmeier T. Endometriosis and Uterine Fibroids (Leiomyomata): Comorbidity, Risks and Implications. Front Reprod Health. 2021;3:750018. http://doi.org/10.3389/frph.2021.750018.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Geethamala K, Murthy VS, Vani BR, Rao S. Uterine Leiomyomas: An ENIGMA. J Midlife Health. 2016;7(1):22–27. http://doi.org/10.4103/0976-7800.179170.</mixed-citation><mixed-citation xml:lang="en">Geethamala K, Murthy VS, Vani BR, Rao S. Uterine Leiomyomas: An ENIGMA. J Midlife Health. 2016;7(1):22–27. http://doi.org/10.4103/0976-7800.179170.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Lin KY, Yang CY, Lam A, Chang CY, Lin WC. Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women. PLoS ONE. 2021;16(8):e0256772. http://doi.org/10.1371/journal.pone.0256772.</mixed-citation><mixed-citation xml:lang="en">Lin KY, Yang CY, Lam A, Chang CY, Lin WC. Uterine leiomyoma is associated with the risk of developing endometriosis: A nationwide cohort study involving 156,195 women. PLoS ONE. 2021;16(8):e0256772. http://doi.org/10.1371/journal.pone.0256772.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Masuda T, Low SK, Akiyama M, Hirata M, Ueda Y, Matsuda K et al. GWAS of five gynecologic diseases and cross-trait analysis in Japanese. Eur J Hum Genet. 2020;28(1):95–107. http://doi.org/10.1038/s41431-019-0495-1.</mixed-citation><mixed-citation xml:lang="en">Masuda T, Low SK, Akiyama M, Hirata M, Ueda Y, Matsuda K et al. GWAS of five gynecologic diseases and cross-trait analysis in Japanese. Eur J Hum Genet. 2020;28(1):95–107. http://doi.org/10.1038/s41431-019-0495-1.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gallagher CS, Mäkinen N, Harris HR, Rahmioglu N, Uimari O, Cook JP et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun. 2019;10(1):4857. http://doi.org/10.1038/s41467-019-12536-4.</mixed-citation><mixed-citation xml:lang="en">Gallagher CS, Mäkinen N, Harris HR, Rahmioglu N, Uimari O, Cook JP et al. Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis. Nat Commun. 2019;10(1):4857. http://doi.org/10.1038/s41467-019-12536-4.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Dvornyk V. Integrated in-depth bioinformatic analysis suggests RELCH/ KIAA1468, LINC02341, and AKAP11 as candidate genes for ages at menarche and menopause. Research Results in Biomedicine. 2021;7(3):220–231. http://doi.org/10.18413/2658-6533-2021-7-3-0-2.</mixed-citation><mixed-citation xml:lang="en">Dvornyk V. Integrated in-depth bioinformatic analysis suggests RELCH/ KIAA1468, LINC02341, and AKAP11 as candidate genes for ages at menarche and menopause. Research Results in Biomedicine. 2021;7(3):220–231. http://doi.org/10.18413/2658-6533-2021-7-3-0-2.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Головченко ИО. Генетические детерминанты уровня половых гормонов у больных эндометриозом. Научные результаты биомедицинских исследований. 2023;9(1):5–21. http://doi.org/10.18413/2658-6533-2023-9-1-0-1.</mixed-citation><mixed-citation xml:lang="en">Golovchenko IO. Genetic determinants of sex hormone levels in endometriosis patients. Research Results in Biomedicine. 2023;9(1):5–21. (In Russ.) http://doi.org/10.18413/2658-6533-2023-9-1-0-1.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Демакова НА. Молекулярно-генетические характеристики пациенток с гиперплазией и полипами эндометрия. Научный результат. Медицина и фармация. 2018;4(2):26–39. http://doi.org/10.18413/2313-8955-2018-4-2-0-4.</mixed-citation><mixed-citation xml:lang="en">Demakova NA. Molecular and genetic characteristics of patients with hyperplasia and endometric polyps. Research Result. Medicine and Pharmacy. 2018;4(2):26–39. (In Russ.) http://doi.org/10.18413/2313-8955-2018-4-2-0-4.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ponomarenko I, Reshetnikov E, Polonikov A, Verzilina I, Sorokina I, Yermachenko A et al. Candidate Genes for Age at Menarche Are Associated With Uterine Leiomyoma. Front Genet. 2021;11:512940. http://doi.org/10.3389/fgene.2020.512940.</mixed-citation><mixed-citation xml:lang="en">Ponomarenko I, Reshetnikov E, Polonikov A, Verzilina I, Sorokina I, Yermachenko A et al. Candidate Genes for Age at Menarche Are Associated With Uterine Leiomyoma. Front Genet. 2021;11:512940. http://doi.org/10.3389/fgene.2020.512940.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Головченко ИО, Пономаренко ИВ, Чурносов МИ. Генетические факторы развития эндометриоза (данные полногеномных исследований). Российский вестник акушера-гинеколога. 2022;22(3):30–36. https://doi.org/10.17116/rosakush20222203130.</mixed-citation><mixed-citation xml:lang="en">Golovchenko IO, Ponomarenko IV, Churnosov MI. Genetic factors of endometriosis development (Data from full genome studies). Russian Bulletin of Obstetrician-Gynecologist. 2022;22(3):30–36. (In Russ.) https://doi.org/10.17116/rosakush20222203130.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко ИВ, Полоников АВ, Чурносов МИ. Ассоциация полиморфизма ESR2 rs4986938 с развитием гиперплазии эндометрия. Акушерство и гинекология. 2019;(4):66–72. https://doi.org/10.18565/aig.2019.4.66-72.</mixed-citation><mixed-citation xml:lang="en">Ponomarenko IV, Polonikov AV, Churnosov MI. Association of ESR2 rs4986938 polymorphism with the development of endometrial hyperplasia. Akusherstvo i Ginekologiya (Russian Federation). 2019;(4):66–72. (In Russ.) https://doi.org/10.18565/aig.2019.4.66-72.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877-81. https://doi.org/10.1093/nar/gkv1340.</mixed-citation><mixed-citation xml:lang="en">Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877-81. https://doi.org/10.1093/nar/gkv1340.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Москаленко МИ, Пономаренко ИВ, Полоников АВ, Чурносов МИ. Полиморфный локус rs652438 гена MMP12 ассоциирован с развитием артериальной гипертензии у женщин. Артериальная гипертензия. 2019;25(1):60–65. https://doi.org/10.18705/1607-419X-2019-25-1-60-65.</mixed-citation><mixed-citation xml:lang="en">Moskalenko MI, Ponomarenko IV, Polonikov AV, Churnosov MI. Polymorphic locus rs652438 of the MMP12 gene is associated with the development of hypertension in women. Arterial Hypertension (Russian Federation). 2019;25(1):60–65. (In Russ.) https://doi.org/10.18705/1607-419X-2019-25-1-60-65.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–575. http://doi.org/10.1086/519795.</mixed-citation><mixed-citation xml:lang="en">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–575. http://doi.org/10.1086/519795.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Ruth KS, Campbell PJ, Chew S, Lim EM, Hadlow N, Stuckey BG et al. Genomewide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur J Hum Genet. 2016;24:284–290. http://doi.org/10.1038/ejhg.2015.102.</mixed-citation><mixed-citation xml:lang="en">Ruth KS, Campbell PJ, Chew S, Lim EM, Hadlow N, Stuckey BG et al. Genomewide association study with 1000 genomes imputation identifies signals for nine sex hormone-related phenotypes. Eur J Hum Genet. 2016;24:284–290. http://doi.org/10.1038/ejhg.2015.102.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко ИВ, Полоников АВ, Чурносов МИ. Молекулярные механизмы и факторы риска развития эндометриоза. Акушерство и гинекология. 2019;(3):26–31. https://doi.org/10.18565/aig.2019.3.26-31.</mixed-citation><mixed-citation xml:lang="en">Ponomarenko IV, Polonikov AV, Churnosov MI. Molecular mechanisms of and risk factors for endometriosis. Akusherstvo i Ginekologiya (Russian Federation). 2019;(3):26–31. (In Russ.) https://doi.org/10.18565/aig.2019.3.26-31.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко ИВ, Полоников АВ, Чурносов МИ. Гиперпластические процессы эндометрия: этиопатогенез, факторы риска, полиморфизм генов – кандидатов. Акушерство и гинекология. 2019;(1):13–18. http://doi.org/10.18565/aig.2019.1.13-18.</mixed-citation><mixed-citation xml:lang="en">Ponomarenko IV, Polonikov AV, Churnosov MI. Endometrial hyperplastic processes: etiopathogenesis, risk factors, polymorphism of candidate genes. Akusherstvo i Ginekologiya (Russian Federation). 2019;(1):13–18. (In Russ.) http://doi.org/10.18565/aig.2019.1.13-18.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Пономаренко ИВ, Чурносов МИ. Современные представления об этиопатогенезе и факторах риска лейомиомы матки. Акушерство и гинекология. 2018;(8):27–32. https://doi.org/10.18565/aig.2018.8.27-32.</mixed-citation><mixed-citation xml:lang="en">Ponomarenko IV, Churnosov MI. Current views on the etiopathogenesis and risk factors of uterine leiomyoma. Akusherstvo i Ginekologiya (Russian Federation). 2018;(8):27–32. (In Russ.) https://doi.org/10.18565/aig.2018.8.27-32.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Klemmt PAB, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Curr Womens Health Rev. 2018;14(2):106–116. https://doi.org/10.2174/1573404813666170306163448.</mixed-citation><mixed-citation xml:lang="en">Klemmt PAB, Starzinski-Powitz A. Molecular and Cellular Pathogenesis of Endometriosis. Curr Womens Health Rev. 2018;14(2):106–116. https://doi.org/10.2174/1573404813666170306163448.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50–60. https://doi.org/10.1016/j.bpobgyn.2018.01.006.</mixed-citation><mixed-citation xml:lang="en">Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol. 2018;50:50–60. https://doi.org/10.1016/j.bpobgyn.2018.01.006.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Liang Y, Xie H, Wu J, Liu D, Yao S. Villainous role of estrogen in macrophagenerve interaction in endometriosis. Reprod Biol Endocrinol. 2018;16(1):122. https://doi.org/10.1186/s12958-018-0441-z.</mixed-citation><mixed-citation xml:lang="en">Liang Y, Xie H, Wu J, Liu D, Yao S. Villainous role of estrogen in macrophagenerve interaction in endometriosis. Reprod Biol Endocrinol. 2018;16(1):122. https://doi.org/10.1186/s12958-018-0441-z.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Bernstein K, Vink JY, Fu XW, Fu XW, Wakita H, Danielsson J et al. Calciumactivated chloride channels anoctamin 1 and 2 promote murine uterine smooth muscle contractility. Am J Obstet Gynecol. 2014;211:688.e1-688.e10. http://doi.org/10.1016/j.ajog.2014.06.018.</mixed-citation><mixed-citation xml:lang="en">Bernstein K, Vink JY, Fu XW, Fu XW, Wakita H, Danielsson J et al. Calciumactivated chloride channels anoctamin 1 and 2 promote murine uterine smooth muscle contractility. Am J Obstet Gynecol. 2014;211:688.e1-688.e10. http://doi.org/10.1016/j.ajog.2014.06.018.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
